REGEN BIOPHARMA, INC. (RGBPP) Financial Statements
REGEN BIOPHARMA, INC. (RGBPP) files with the U.S. Securities and Exchange Commission under CIK 0001589150. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $236.56 thousand
- Net Income
- -$1.27 million
- Total Assets
- $274.63 thousand
- Net Cash from Operations
- -$383.59 thousand
Fiscal year ended Sep 30, 2025. Latest periodic SEC filing: Aug 17, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for RGBPP in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History